![Myriam Mendila](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Myriam Mendila
Director Técnico/Científico/I+D en
CUREVAC
.
Perfil
Myriam Mendila currently works at CureVac NV, as Chief Scientific Officer, Head-R&D.
Dr. Mendila also formerly worked at Novartis Pharma AG, as Chief Medical Officer-Oncology.
Dr. Mendila received her doctorate degree from Hannover Medical School.
Cargos activos de Myriam Mendila
| Empresas | Cargo | Inicio |
|---|---|---|
| CUREVAC | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Myriam Mendila.
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Formación de Myriam Mendila.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
2
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Bolsa de valores
- Insiders
- Myriam Mendila
